Abstract:The efficacy of intranasal triamcinolone acetonide in seasonal and allergic rhinitis has been evaluated in clinical trials and has been compared with antihistamines and other intranasal corticosteroids. Intranasal corticosteroids are either as equally effective as or more effective than comparative drugs. Intranasal corticosteroids are particularly useful as they decrease membrane permeability and inhibit both early and late phase reactions to allergens. They minimise the nasal secretory response and reduce th… Show more
“…In a risk‐benefit analysis, it has been associated with markedly few adverse side effects 4. As such, The International Consensus Conference Proceedings on Rhinitis recommend intranasal steroids as a first line therapy in allergic rhinosinusitis 5. However, in the postoperative time frame, the use of topical corticosteroid sprays, in an effort to prevent recurrence of chronic rhinosinusitis with polyposis, has met with mixed results 6.…”
Data analysis suggests a significant improvement in early postoperative healing in nasal cavities receiving triamcinolone-impregnated absorbable nasal packing following ESS and is also associated with improved healing up to 6 months postoperatively.
“…In a risk‐benefit analysis, it has been associated with markedly few adverse side effects 4. As such, The International Consensus Conference Proceedings on Rhinitis recommend intranasal steroids as a first line therapy in allergic rhinosinusitis 5. However, in the postoperative time frame, the use of topical corticosteroid sprays, in an effort to prevent recurrence of chronic rhinosinusitis with polyposis, has met with mixed results 6.…”
Data analysis suggests a significant improvement in early postoperative healing in nasal cavities receiving triamcinolone-impregnated absorbable nasal packing following ESS and is also associated with improved healing up to 6 months postoperatively.
“…La diffusion systémique des corticoïdes administrés par la voie intranasale diffère d'une molécule à l'autre. Le budésonide et le fluticasone propionate passent significativement dans la circulation générale [9]. Il semble que l'administration intranasale de corticoïdes n'induit pas de cataracte (n = 225 dont 70 % traités béclométasone dipropionate) [10], même si quelques cas sont rapportés [11].…”
Section: Complications Ophtalmologiques Des Corticoïdes Par Voie Généunclassified
“…The placebo improved symptoms of sneezing, nasal blockage, rhinorrhoea and pruritus (Di Lorenzo et al, 1999). Furthermore, it is recommended the use of triamcinolone as the intranasal corticosteroid of choice in AR at a recommended dose of 220 micrograms once a day (Gawchik & Saccar, 2000).…”
Section: Side Effects Safety and Tolerance Of Glucocorticosteroidsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.